Rodolfo Haedo

Statistics

Publications

Citations

420

H-Index

Active since

2006

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

Rodolfo Haedo is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in medicinal chemistry, calcium signaling, and pharmacology.

Publications per year

2006–2020

Publications

Analgesic Effects of a Substituted N-Triazole Oxindole (TROX-1), a State-Dependent, Voltage-Gated Calcium Channel 2 Blocker

Catherine Abbadie, Owen B. McManus, Shu-Yu Sun et al. · Journal of Pharmacology and Experimental Therapeutics · 2010 · 98 citations

Medicine, Medicinal Chemistry, Pharmacology +17

Characterization of the Substituted N-Triazole Oxindole TROX-1, a Small-Molecule, State-Dependent Inhibitor of Cav2 Calcium Channels

Andrew M. Swensen, James Herrington, Randal M. Bugianesi et al. · Molecular Pharmacology · 2011 · 66 citations

Medicine, Medicinal Chemistry, Pharmacology +17

A High-Throughput Assay for Evaluating State Dependence and Subtype Selectivity of Cav2 Calcium Channel Inhibitors

Ge Dai, Rodolfo Haedo, Vivien A. Warren et al. · Assay and Drug Development Technologies · 2008 · 58 citations

Life Sciences, Neuroscience, Pharmacology +17

Ionic Mechanism Underlying Recovery of Rhythmic Activity in Adult Isolated Neurons

Rodolfo Haedo, Jorge Golowasch · Journal of Neurophysiology · 2006 · 53 citations · Full text

Life Sciences, Neurobiology, Neuroscience +17

A Pharmacologically Validated, High-Capacity, Functional Thallium Flux Assay for the Human <i>Ether-à-go-go</i> Related Gene Potassium Channel

William A. Schmalhofer, Andrew M. Swensen, Brande S. Thomas et al. · Assay and Drug Development Technologies · 2010 · 33 citations

Medicine, Cardiology, Medicinal Chemistry +17

1–5 of 10